Cited 0 times in
Phase II randomized study of neoadjuvant metformin plus letrozole versus placebo plus letrozole for ER-positive postmenopausal breast cancer [METEOR Study]
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, J | - |
dc.contributor.author | Han, W | - |
dc.contributor.author | Kim, EK | - |
dc.contributor.author | Jung, Y | - |
dc.contributor.author | Kim, HA | - |
dc.contributor.author | Chae, SM | - |
dc.contributor.author | Lee, ES | - |
dc.contributor.author | Ahn, SH | - |
dc.contributor.author | Kim, TH | - |
dc.contributor.author | Jeong, J | - |
dc.contributor.author | Choi, SY | - |
dc.contributor.author | Nam, SJ | - |
dc.contributor.author | Paik, NS | - |
dc.contributor.author | Kim, LS | - |
dc.contributor.author | Gong, G | - |
dc.contributor.author | Yu, JH | - |
dc.contributor.author | Jung, SY | - |
dc.contributor.author | Kim, HJ | - |
dc.contributor.author | Ahn, SG | - |
dc.contributor.author | Kim, MK | - |
dc.date.accessioned | 2022-01-14T05:17:05Z | - |
dc.date.available | 2022-01-14T05:17:05Z | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 0732-183X | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/19985 | - |
dc.title | Phase II randomized study of neoadjuvant metformin plus letrozole versus placebo plus letrozole for ER-positive postmenopausal breast cancer [METEOR Study] | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Jung, Y | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1200/JCO.2019.37.15_suppl.576 | - |
dc.citation.title | Journal of clinical oncology | - |
dc.citation.volume | 37 | - |
dc.citation.number | 15_suppl | - |
dc.citation.date | 2019 | - |
dc.citation.startPage | 576 | - |
dc.citation.endPage | 576 | - |
dc.identifier.bibliographicCitation | Journal of clinical oncology, 37(15_suppl). : 576-576, 2019 | - |
dc.embargo.liftdate | 9999-12-31 | - |
dc.embargo.terms | 9999-12-31 | - |
dc.identifier.eissn | 1527-7755 | - |
dc.relation.journalid | J00732183X | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.